Enovis Corporation

NYSE:ENOV

Medical - Devices

Healthcare
$27.10 +3.50%

+$0.73 today

Market cap
$1.56B
Beta
1.49
P/E (TTM)
-1.1
EPS (TTM)
-$20.02
52W Low $20.55High $36.82

Volume 0.88M

Average 0.99M

ENOV Operating Expenses

Total costs of running the business that are not directly tied to producing goods or services sold.

Enovis CorporationNYSE: ENOV

Operating Expenses · Q1 FY2026 · quarter ended Apr 2026

Operating expenses declines year over year

Q1 FY2026 operating expenses of $303.31M fell 19.1% year over year, ahead of the -38.3% change in trailing-twelve-month operating expenses. Sequentially, it rose 0.7% from the prior quarter. Over 3 fiscal years it compounded at +13.2% a year.

Context

  • Operating expenses amounted to 60.7% of revenue in FY2025, down 32.1 pp from a year earlier.
  • Operating expenses increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -19.1% holds above the trailing-twelve-month pace of -38.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterApr 2026
$303.31M+0.7% QoQ
Last fiscal yearDec 2025
$1.36B-30.3% YoY
LTMApr 2026
$1.23B-38.3% YoY
Operating Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-19.1%——
1 year-30.3%——
3-year CAGR+13.2%——
5-year CAGR——
10-year CAGR——

Operating Expenses history

USD · from the income statement

Latest · FY2025
1.36B USD
Year-over-year change
-30.3%
4-year CAGR
+12.9%

Operating Expenses vs competitors

How ENOV compares with its peers on the latest reported figures

  • ENOV's LTM Apr 2026 operating expenses of $1.23B is the 2nd highest of the 16 companies compared; the peer median is $338.75M.
  • Its year-over-year change of -38.3% is the lowest of 16, against a peer median of +12.0%.
  • Operating expenses amounts to 54.1% of revenue for ENOV, versus a peer median of 23.9%.
ENOV Competitors Peer median
Operating Expenses for ENOV and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MIDDThe Middleby CorporationLTM Jul 2026$1.47B +78.8%-6.3%41.1%
ENOVEnovis CorporationLTM Apr 2026$1.23B -38.3%+13.2%54.1%
ITTITT Inc.LTM Jul 2026$884.9M +47.6%+15.9%18.7%
IEXIDEX CorporationLTM Jun 2026$858.5M +14.0%+0.6%23.9%
WTSWatts Water Technologies, Inc.LTM Jun 2026$792.5M +12.7%+9.5%29.6%
DCIDonaldson Company, Inc.LTM Jul 2026$746M -5.7%+3.1%19.2%
FELEFranklin Electric Co., Inc.LTM Sep 2026$516.33M +6.5%+3.7%22.8%
NPOEnPro Industries, Inc.LTM Jun 2026$346M +12.0%-2.5%28.3%
KAIKadant Inc.LTM Jul 2026$338.75M +13.0%+13.3%29.4%
HLIOHelios Technologies, Inc.LTM Jul 2026$201.9M +20.5%+8.4%22.7%
EPACEnerpac Tool Group Corp.LTM Feb 2026$175.41M -0.1%-10.7%28.1%
GRCThe Gorman-Rupp CompanyLTM Jun 2026$110.35M -3.4%+3.8%15.7%
LXFRLuxfer Holdings PLCLTM Mar 2026$52.5M -5.9%+2.1%14.1%
HURCHurco Companies, Inc.LTM Apr 2026$44.45M +0.3%-5.8%24.5%
GHMGraham CorporationLTM Mar 2026$43.35M +15.1%+21.5%17.7%
OFLXOmega Flex, Inc.LTM Mar 2026$39.07M -4.0%-6.8%39.8%
Peer median (excluding ENOV) $338.75M+12.0%+3.1%23.9%

Competitors are the stored peer set for ENOV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.43B1.56B1.71B2.11B2.25B
Cost of Revenue648.51M693.72M716.42M926.87M902.79M
Gross Profit777.68M869.38M990.78M1.18B1.35B
Gross Margin54.5%55.6%58.0%56.0%59.8%
Research & Development49.09M60.83M75.33M91.3M120.33M
Selling, General & Admin665.78M772.91M830.31M939.36M1.07B
Operating Expenses840.47M940.56M1.06B1.96B1.36B
Depreciation & Amortization262.92M219.71M217.11M284.8M294.38M
EBITDA170.25M241.69M169.73M(481.03M)(830.22M)
EBITDA Margin11.9%15.5%9.9%-22.8%-36.9%
Operating Income(62.8M)(71.18M)(65.71M)(775.72M)(18.87M)
Operating Margin-4.4%-4.6%-3.8%-36.8%-0.8%
Interest Income0200K000
Interest Expense29.11M24.95M19.75M57.1M34.82M
Other Income / Expenses(58.98M)69.11M(1.42M)(47.21M)(1.14B)
Income Before Tax(121.78M)(2.07M)(67.13M)(822.92M)(1.16B)
Pre-Tax Margin-8.5%-0.1%-3.9%-39.0%-51.6%
Income Tax Expense(19.53M)36.12M(13.29M)4.49M22.29M
Net Income71.66M(13.29M)(33.26M)(825.49M)(1.18B)
Net Margin5.0%-0.9%-1.9%-39.2%-52.7%
EPS (Basic)(2.02)(0.28)(0.61)(14.93)(20.86)
EPS (Diluted)(2.02)(0.28)(0.61)(14.93)(20.86)
Weighted Avg Shares51.14M54.07M54.53M55.28M56.79M
Weighted Avg Shares (Diluted)51.14M54.07M54.49M55.28M56.79M

Enovis Corporation

NYSE:ENOV

Intrinsic Alpha fair value

Locked

Current Price

$27.10

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.